NEW YORK, NY / ACCESSWIRE / October 4, 2017 / All three of the U.S. major indexes reached new records for the second consecutive session as recent economic data continues to support a healthy U.S. economy. The Dow Jones Industrial Average gained 0.37 percent to close at 22,641.67, its fifth consecutive daily gain, while the S&P 500 Index rose 0.22 percent to close at 2,534.58. The tech-heavy NASDAQ Composite Index rose 0.23 percent to close at 6,531.71. On Tuesday, Ford, General Motors and Toyota all reported better-than-expected sales in September.

"We're seeing moves into economically sensitive stocks, which is an indication that investors believe some of the favorable economic data that's coming out," said Bucky Hellwig, Senior Vice President at BB&T Wealth Management in Birmingham, Alabama, according to Reuters.

RDI Initiates Coverage on:

GW Pharmaceuticals Plc
https://rdinvesting.com/news/?ticker=GWPH

Zogenix Inc.
https://rdinvesting.com/news/?ticker=ZGNX

GW Pharmaceuticals Plc's stock jumped 5.30% Tuesday, to close the day at $103.73. The stock recorded a trading volume of 626,688 shares, which was above its three months average volume of 347,992 shares. In the last year, GW Pharmaceuticals Plc's shares have traded in a range of 92.65 - 137.88. The stock is currently trading 24.77% below its 52-week high. The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $105.31 is below its 200-day moving average of $108.39. Shares of GW Pharmaceuticals have fallen approximately 7.18 percent year-to-date.

Access RDI's GW Pharmaceuticals Plc Research Report at:
https://rdinvesting.com/news/?ticker=GWPH

On Tuesday, shares of Zogenix Inc. recorded a trading volume of 8,941,605 shares, which was above the three months average volume of 1,138,800 shares. The stock ended the day 0.13% lower at 38.85. The share price has gained 418.00% from its 52-week low with a 52-week trading range of 7.50 - 41.65.The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $14.63 is greater than its 200-day moving average of $13.07. Shares of Zogenix have gained approximately 219.75 percent year-to-date.

Access RDI's Zogenix Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ZGNX

Our Actionable Research on GW Pharmaceuticals Plc (NASDAQ: GWPH) and Zogenix Inc. (NASDAQ: ZGNX) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com